Despite these challenges, the PGD market is expected to grow significantly in the coming years due to the increasing demand for PGD, the growing prevalence of genetic disorders, and the increasing adoption of IVF procedures. Key players in the market are investing in research and development to improve the accuracy and affordability of PGD and to develop new technologies.
In conclusion, the Preimplantation Genetic Diagnosis Market is expected to grow significantly in the coming years due to the increasing demand for PGD and the growing prevalence of genetic disorders. Key players in the market are investing in research and development to improve the accuracy and affordability of PGD and to develop new technologies. However, the high cost of PGD and ethical concerns related to the selection of gender or other traits of the embryo are major factors that could hamper the growth of the PGD market.
